Advertisement

Topics

Search Results for "Cvs Minute Clinic Shingles Vaccine"

14:52 EDT 23rd July 2017 | BioPortfolio

Matching Channels

Varicella

Varicella zoster virus (VZV) is one of eight herpes viruses known to infect humans (and other vertebrates). Varicella-zoster virus is known by many names, including: chickenpox virus, varicella viru...

HPV vaccine

Rotavirus Vaccine GSK

Smallpox Vaccine MVA

Poliovirus Vaccine OPV

Matching News

GSK and Daiichi Sankyo JV submits NDA for candidate shingles vaccine in Japan

GlaxoSmithKline (GSK) and Daiichi Sankyo joint venture (JV) Japan Vaccine Co has submitted a New Drug Application (NDA) in Japan for candidate shingles vaccine, Shingrix.

Vaccination may be curbing ER visits for shingles

(Reuters Health) - Emergency room (ER) visits for shingles fell in the past decade for people aged 60 and older but rose for most younger age groups. The decrease among older people may be due to more...

Shingles vaccine cuts chronic pain, hospitalizations

(HealthDay)—Vaccination greatly reduces the risk of serious complications from shingles, a new study finds.

GSK’s shingles vaccine Shingrix succeeds in phase 3 revaccination trial

GSK’s shingles vaccine candidate Shingrix (HZ/su) met its primary objective of inducing a strong immune response in older patients in a phase 3 revaccination trial.

GSK presents new Phase III data on candidate shingles vaccine Shingrix

GlaxoSmithKline is releasing new results from a clinical study showing that its candidate vaccine for…

Norway Brings Another Cancer Vaccine to the Clinic

Targovax has recruited its first patient in a Phase Ib trial for its new cancer vaccine TG02 targeting mutations of the RAS gene. Mutations of the RAS gene disrupt normal cell division and are a key ...

Where Others Failed, a Vaccine for Dementia Shows Potential in the Clinic

AXON Neuroscience has presented positive clinical results for its Alzheimer’s vaccine and announced a new trial to extend its use to other forms of dementia. Neurodegenerative diseases such as A...

Identifying underlying causes of immune deficiencies that increase shingles risk

(JCI Journals) Varicella zoster virus can remain dormant for decades and reactivate to cause shingles. Shingles occurs at a higher rate in immunocompromised individuals. A study published this week in...

Matching PubMed Articles

A critical appraisal of 'Shingrix', a novel Herpes Zoster Subunit (HZ/Su or GSK1437173A) vaccine for Varicella Zoster Virus.

HZ/Su, branded as 'Shingrix', is one of the newest vaccines to be submitted for multi-national regulatory approval. It is targeted to prevent shingles, predominantly affecting the elderly, but a globa...

Vaccination Coverage Among Adults With Diagnosed Diabetes: United States, 2015.

Data from the National Health Interview Survey •Among adults aged 18 and over with diagnosed diabetes, 61.6% had an influenza vaccine in the past year. •A total of 52.6% of adults with diagnosed d...

Preventing herpes zoster through vaccination: New developments.

Herpes zoster (HZ) affects 1 million Americans every year. The disease burden is higher in immunocompromised patients. The live-attenuated HZ vaccine is effective in preventing HZ and postherpetic neu...

Addressing a Yellow Fever Vaccine Shortage - United States, 2016-2017.

Recent manufacturing problems resulted in a shortage of the only U.S.-licensed yellow fever vaccine. This shortage is expected to lead to a complete depletion of yellow fever vaccine available for the...

Longitudinal Trends in Vaccine Hesitancy in a Cohort of Mothers Surveyed in Washington State, 2013-2015.

Parents who refuse or delay vaccines because of vaccine hesitancy place children at increased risk for vaccine-preventable disease. How parental vaccine hesitancy changes as their children age is not ...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement